🇺🇸 FDA
Drug

clofazimine

Brand: LAMPRENE

approved

Quick answer

clofazimine (LAMPRENE), is a pharmaceutical active ingredient, with approved status in the US.

Key facts

INN
clofazimine
Brand
LAMPRENE
Route
ORAL
Formulation
CAPSULE

Related patents

patent

US 11090326

Fixed-dose pharmaceutical composition comprising rifabutin, clarithromycin, and

Expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10143702

Fixed-dose pharmaceutical composition comprising rifabutin, clarithromycin, and

Expires Mon Nov 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9314477

Compositions comprising rifabutin, clarithromycin, and clofazimine and uses ther

Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9198926

Methods and compositions comprising rifabutin, clarithromycin, and clofazimine

Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is clofazimine?

clofazimine (LAMPRENE), is a pharmaceutical active ingredient, with approved status in the US.

What is the brand name for clofazimine?

LAMPRENE is a marketed brand name for clofazimine. Check FDA Drugs@FDA for the current US label holder.